RE:RE:2nd Quarter
Pretty decent quarterly report, right in line with their current growth pattern.
I guess cultivation is the wild card here. I am very skeptical that they can achieve a 100% return on capital in a year, but we will see.
That purchase depletes a good chunk of their cash. I suppose that the saving grace is that the dispensaries will continue to prop the company up until the cultivation assets (theoretically) show a return.
The market appears to like management's recent actions and the quarterly report, so I can't complain.
I think we're at a wait-and-see point right now. I'd sure like to know the individual numbers for the dispensaries, especially Palm Springs. The company says that the cultivation will increase margins, so the next couple of quarters should demonstrate this.
Any input or opinion is welcomed. I'll try to post on here more regularly.